Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old
D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children
D2.342 - Changes of MMP-9 and MMP-12 in response of acute viral infection in virtual model of macrophages
D2.343 - Use of IDDA 2.1 score in Common Variable Immunodeficiency (CVID): a single center experience
D2.344 - Unraveling the Mysteries of Chronic Granulomatous Disease: A Case of detected Protein Deficiency Amidst Negative Genetic Screening
D2.345 - Conformations of HVEM engaged in its Trans and Cis interactions are caused by two kinds of post-translational folding
D2.346 - Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer
D2.347 - Allergen-Specific T Cells to House Dust Mite are absent on the circulation of local allergic rhinitis patients
D2.348 - Clinical Course of Hereditary Angioedema Patients Transitioning off Androgens
D2.349 - Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities
D2.350 - CVID: the crossroad between immune dysregulation, autoimmunity and cancer
D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392 - What information and education is crucial for people with food allergies?
D3.393 - Daily life with a peanut allergy, as a young adult- an interview study
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.395 - Evaluation for suspected penicillin allergy - the patient perspective
D3.398 - Food provision experience of inpatients with adverse food reactions in the acute hospital setting
Download the app
The congress at your fingertips
Available on
Download